Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-07-05

Clinical Trial Update: Role of Positron Emission Tomography in the Evaluation of Response to Sorafenib in Advanced Hepatocellular Carcinoma [NA]

View source ↗

Summary

This completed clinical trial evaluated the role of positron emission tomography in assessing response to sorafenib in patients with advanced hepatocellular car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sorafenib (Nexavar) (Sorafenib)

Snippet

Sponsor: Hospital Miguel Servet | Conditions: Hepatocellular Carcinoma | NA | Status: COMPLETED